Skip to main content
. 2020 Jan 6;9(2):122–134. doi: 10.1530/EC-19-0510

Table 1.

Gene expression changes after mitotane treatment of control cells or after development of resistance (selection).

Gene Log2 FC Exp Adj P Comparison
SCARB1 −2.54 7.76 2.4 × 10−20 Resistant DMSO vs Nonresistant DMSO
HSD3B2 −5.77 5.33 5.98 × 10−18 Resistant DMSO vs Nonresistant DMSO
CYP11A1 −3.66 6.45 1.01 × 10−17 Resistant DMSO vs Nonresistant DMSO
CYP21A2 −4.34 6.61 7.49 × 10−17 Resistant DMSO vs Nonresistant DMSO
IGF1 4.24 5.74 2.94 × 10−14 Resistant DMSO vs Nonresistant DMSO
STAR −3.52 7.14 4.17 × 10−14 Resistant DMSO vs Nonresistant DMSO
AXIN2 1.59 6.87 2.2 × 10−13 Resistant DMSO vs Nonresistant DMSO
SOAT1 −1.95 7.35 1.64 × 10−12 Resistant DMSO vs Nonresistant DMSO
DDIT3 1.55 5.94 2.55 × 10−8 Nonresistant Mitotane vs Nonresistant DMSO
GDF15 1.87 5.9 8.19 × 10−6 Nonresistant Mitotane vs Nonresistant DMSO
SREBF1 −1.14 6.16 8.4  × 10−6 Nonresistant Mitotane vs Nonresistant DMSO
XBP1 0.75 6.96 7.29 × 10−4 Nonresistant Mitotane vs Nonresistant DMSO

Only genes referenced in results section are listed.

Adj P, adjusted P value; DMSO, dimethyl sulfoxide; Exp, average expression; Log2 FC, log2 fold change.